ONKURE THERAPEUTICS, INC. (OKUR) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Current obligations | 6.64M USD | Liabilities, Current |
| Cash and equivalents | 166.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 9.88M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $6.64M | $166.50M | $9.88M | (m) | (m) | (m) |
| 2026-03-31 | (m) | $14.33M | $192.11M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $5.92M | $59.05M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $6.25M | $70.33M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $7.60M | $83.37M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $8.79M | $96.66M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $10.53M | $110.76M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $3.25M | $60.69M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $1.35M | $35.97M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $2.81M | $20.38M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $18.18M | $27.63M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $13.56M | $11.74M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $13.74M | $9.08M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $10.48M | $30.39M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $7.12M | $19.93M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $9.45M | $62.13M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $8.34M | $118.26M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $7.91M | $121.09M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $6.20M | $124.66M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $6.35M | $126.41M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $3.34M | $140.37M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $3.93M | $91.22M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $4.58M | $53.61M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |